Skip to main content
. 2020 Jun 27;142(5):441–454. doi: 10.1161/CIRCULATIONAHA.120.046928

Figure 6.

Figure 6.

Pharmacodynamic and pharmacokinetic effects of cangrelor, tirofiban, and prasugrel (chewed or integral) in patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention 30 minutes after drug administration. ADP indicates adenosine diphosphate; and TRAP, thrombin receptor agonist peptide.